3. Combined expression of PGC-MG7 in different gastric diseases.
| PGC-MG7 combination | Gastric diseases [n (%)] | GC risk | ||||
| NAG | AG | GC | OR (95% CI) | P** | ||
| *, vs. other combinations; **, D type as control; adjusted by age and sex; PGC, pepsinogen C; NAG, non-atrophic gastritis; AG, atrophic gastritis; GC, gastric cancer; OR, odds ratio; 95% CI, 95% confidence interval. | ||||||
| A type | 111 (79.3)* | 2 (2.9) | 1 (1.3) | 0.009 (0.001−0.064) | <0.001 | |
| B type | 8 (5.7) | 10 (14.7) | 3 (3.9) | 0.110 (0.031−0.445) | 0.002 | |
| C type | 18 (12.9) | 15 (22.1) | 2 (2.6) | 0.033 (0.007−0.151) | <0.001 | |
| D type | 3 (2.1) | 41 (60.3)* | 71 (92.2)* | 1.0 | − | |
| Total | 140 (100) | 68 (100) | 77 (100) | − | − | |